GREEN DROITIN
LIVE

Serial Number

79372803

Owner

VIVATIS Pharma GmbH

Attorney

Michelle E. Tochtrop

Filing Date

Feb 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GREEN DROITIN Trademark

Serial Number: 79372803 • Registration: 7510296

GREEN DROITIN is a trademark filed by VIVATIS Pharma GmbH on February 15, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

VIVATIS Pharma GmbH

Grüner Deich 1-3

Entity Type: 16

Hangzhou Skyherb Technologies Co. Ltd.

171 Xiangyuan Rd,

Entity Type: 16

Trademark Details

Filing Date

February 15, 2023

Registration Date

September 24, 2024

Published for Opposition

July 9, 2024

Goods & Services

Retail store services and wholesale store services for others including via mail order and via communications media including the internet all featuring chemical products and substances in the nature of chemicals and substances based on botanical extracts, and chemical and organic compositions for the manufacture of pharmaceuticals; retail store services and wholesale store services for others including via mail order and via communications media including the internet featuring health food supplements for persons with special dietary requirements, sanitary sterilising preparations, nutritional supplements, preparations and substances for dietary use, nutraceuticals, plant extracts for industrial purposes, plant extracts for the food industry, botanical extracts for use in the production of cosmetics, and plant extracts for use in the manufacture of pharmaceuticals; retail store services and wholesale store services for others including by mail order and via communications media including the internet, featuring proteins for use in manufacture, food proteins as a raw material, proteins for use in the manufacture of dietary supplements, and chondroitin preparations; retail store services and wholesale store services for others including via mail order and via communications media including the internet featuring pharmaceuticals, botanical extracts for pharmaceutical purposes, nutritional supplements, preparations and substances for dietary use, nutraceuticals, health food supplements for persons with special dietary requirements, sanitary sterilising preparations, dietary supplements based on mushroom extracts, plant extracts for pharmaceutical purposes, plant extracts for pharmaceutical purposes, and protein dietary supplements; business advice and consultancy relating to franchising

Chondroitin preparations; pharmaceutical preparations for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, diabetes, gastro-intestinal conditions, uro-genital disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, conditions of the skin and tissue, erectile dysfunction, bone diseases or disorders, allergies, metabolic disorders, endocrine diseases, musculoskeletal diseases or disorders, cardiovascular diseases or disorders, cardiopulmonary diseases or disorders, genitourinary diseases or disorders, sexual dysfunction, oncological conditions, hepatological conditions, respiratory diseases or disorders, neurological diseases or disorders, gastrointestinal diseases or disorders, psychiatric conditions, allergic rhinitis, viral infections and diseases, gastro-intestinal diseases, and halitosis, all for use in humans and animals; botanical extracts being plant extracts for pharmaceutical purposes; food supplements, dietetic preparations adapted for medical purposes and nutritive substances for microorganisms for medical use and nutraceuticals for use as dietary supplements; health food supplements for persons with special dietary requirements; sanitary sterilising preparations; nutritional supplements consisting of fungal extracts; plant extracts for pharmaceutical purposes; protein dietary supplements

Chemicals and chemical substances, namely, industrial chemicals and chemical preparations derived from botanical extracts other than for medical or veterinary purposes; chemical and organic compositions, namely, industrial chemicals for the manufacture of pharmaceuticals, sanitary preparations, dietary supplements, dietetic preparations and substances, and nutraceuticals; plant extracts for industrial purposes, namely plant extracts for use in the manufacture of pharmaceutical; plant extracts for the food industry; botanical extracts for use in making cosmetics; plant extracts for use in the manufacture of pharmaceuticals; proteins for use in manufacture; industrial food protein as a raw material; proteins for use in the manufacture of food supplements

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 12, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 29, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 29, 2026 FIMP
CHANGE OF OWNER RECEIVED FROM IB
Nov 21, 2025 DCPN
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 9, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 9, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 9, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 9, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 9, 2025 REAP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 4, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 3, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 7, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 7, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 7, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 7, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 24, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 6, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 6, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 6, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 6, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 3, 2024 TROA
REFUSAL PROCESSED BY IB
Dec 12, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 17, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 17, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 16, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 15, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 9, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 29, 2023 REPR